Boc-Val-Cit-OH

Boc-Val-Cit-OH, also known as tert-Butyloxycarbonyl-L-valyl-L-citrulline, is a synthetic dipeptide derivative widely recognized for its versatile utility in peptide chemistry and bioconjugation strategies. Characterized by the presence of a Boc-protected valine linked to citrulline, this compound offers a unique combination of hydrophobic and polar functionalities, making it particularly suitable for applications requiring selective reactivity and controlled peptide assembly. Its chemical structure facilitates compatibility with solid-phase peptide synthesis (SPPS), allowing researchers to incorporate it into complex peptide sequences with precision. The Boc protecting group ensures stability during synthesis, while the citrulline moiety introduces opportunities for site-specific modifications and linker design. As a result, Boc-Val-Cit-OH has become an indispensable building block in the development of advanced biomolecular constructs, supporting innovation across a spectrum of research fields.

Antibody-Drug Conjugate (ADC) Linker Design: Boc-Val-Cit-OH serves as a critical component in the synthesis of cleavable linkers for antibody-drug conjugates. Its valine-citrulline dipeptide motif is recognized for being selectively cleavable by cathepsin B, a lysosomal enzyme abundantly present in target cells. By integrating this linker into ADCs, researchers can achieve precise drug release profiles, ensuring that cytotoxic payloads are liberated only within the desired cellular environment. The Boc protection further enhances the chemical stability of the linker during upstream synthesis, allowing for efficient conjugation to both antibodies and drug molecules. This application has enabled the development of next-generation targeted therapies with improved therapeutic indices and reduced off-target effects, underscoring the compound's significance in biopharmaceutical innovation.

Peptide Synthesis and Modification: In the realm of peptide chemistry, Boc-Val-Cit-OH is highly valued as a modular building block for constructing custom peptide sequences. Its compatibility with standard SPPS protocols allows for seamless incorporation into growing peptide chains, while the orthogonal Boc group provides an additional layer of control over deprotection steps. Researchers utilize this dipeptide to introduce specific recognition sites or functional handles within peptides, enabling downstream modifications such as labeling, crosslinking, or cyclization. The presence of citrulline, a non-standard amino acid, further expands the structural diversity achievable in synthetic peptides, supporting the creation of novel biomolecules for research and diagnostic applications.

Protease Substrate Development: The unique sequence of valine-citrulline within Boc-Val-Cit-OH renders it an ideal substrate motif for studying protease activity, particularly for cathepsin B and related enzymes. By incorporating this dipeptide into fluorogenic or chromogenic substrates, scientists can monitor proteolytic cleavage events in real time, facilitating the characterization of enzyme kinetics and specificity. Such substrates are instrumental in high-throughput screening assays, enabling the identification of protease inhibitors or modulators with potential research utility. The ability to tailor the peptide's properties through selective modification of the Boc group or the citrulline residue further enhances its adaptability for diverse assay formats.

Targeted Drug Delivery Research: The valine-citrulline sequence present in Boc-Val-Cit-OH is widely employed in the design of drug delivery systems that rely on enzyme-triggered release mechanisms. By conjugating therapeutic agents to carriers via this cleavable linker, researchers can engineer prodrugs or nanocarriers that remain inert in circulation but release their payloads upon encountering specific intracellular enzymes. This strategy enables spatial and temporal control over drug activation, reducing systemic toxicity and enhancing efficacy in preclinical models. The compound's robust chemical properties ensure efficient synthesis and reliable performance in these advanced delivery platforms, supporting ongoing efforts to refine targeted therapy approaches.

Bioconjugation and Biomarker Discovery: Boc-Val-Cit-OH also finds application in bioconjugation strategies aimed at the development of novel diagnostic tools and biomarker discovery platforms. Its dipeptide structure can be employed to link peptides, proteins, or small molecules to reporter tags, affinity handles, or solid supports. This flexibility enables the creation of multifunctional probes for imaging, affinity purification, or biosensor applications. The selective reactivity of the Boc group and the citrulline side chain allows for precise control over conjugation sites, minimizing non-specific interactions and enhancing assay sensitivity. As research in proteomics and molecular diagnostics continues to advance, the utility of Boc-Val-Cit-OH in the construction of specialized bioconjugates remains a key asset for scientific discovery.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

3. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

5. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore